Digbi Health has launched ASRA, an AI-coordinated care platform that unifies management of obesity, diabetes, hypertension, gastrointestinal conditions and women's hormonal health under a single clinical architecture. The system was built on billions of linked data points spanning gut microbiome sequencing, genetics, laboratory values, claims, continuous glucose monitoring and real-world GLP-1 response, with AI agents handling operational workflow while clinicians retain decision authority. It currently supports programs for more than 300 employers and health plans across all 50 states.
Key Points
- Microbiome, genetic and glucose data unified into one care platform
- AI agents handle operations; clinicians retain clinical decision authority
- Deployed across 300+ employers, 30 million eligible individuals nationwide
Longevity Analysis
Metabolic dysfunction, gut disturbance and hormonal decline are rarely isolated events, yet they are typically treated by separate vendors with no shared data. Consolidating microbiome composition, glucose variability, genetic risk and pharmacotherapy response into a single interpretive layer makes it possible to read the signals the digestive tract and endocrine system are already sending rather than treating each downstream symptom in isolation. The operational value lies less in the algorithm than in sustained adherence — longitudinal tracking and structured follow-through remain the determining variables in whether any metabolic intervention produces durable change.
Original published by LT Wire.